Price Chart

Profile

Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform "Nitricil". Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
URL http://pelthos.com
Investor Relations URL https://ir.pelthos.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 26, 2026 (est.)
Last Earnings Release Nov. 13, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform "Nitricil". Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
URL http://pelthos.com
Investor Relations URL https://ir.pelthos.com/
HQ State/Province North Carolina
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 26, 2026 (est.)
Last Earnings Release Nov. 13, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A